Monopar Therapeutics (MNPR)
(Delayed Data from NSDQ)
$4.37 USD
-0.17 (-3.74%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $4.30 -0.07 (-1.60%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.46 | 0.00% |
Earnings Summary
For their last quarter, Monopar Therapeutics (MNPR) reported earnings of -$0.50 per share, missing the Zacks Consensus Estimate of -$0.45 per share. This reflects a negative earnings surprise of 11.11%. Look out for MNPR's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.46 per share, reflecting a year-over-year increase of 34.29%.
Earnings History
Price & Consensus
Zacks News for MNPR
Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
MNPR: What are Zacks experts saying now?
Zacks Private Portfolio Services